Penn Medicine Provider
Pulmonary Medicine
Kevin Ma, MD
4.9
(258)
Accepting new patients
Sees patients age 18 and up
Harron Lung Center Perelman
View 1 additional location
Schedule onlineCall 215-615-5864

About me

  • Clinical Director, Bronchoscopic Lung Volume Reduction Program
  • Co-Chair, Clinical Emergencies Response Committee, Penn Presbyterian Medical Center
  • Associate Professor of Clinical Medicine (Pulmonary, Allergy and Critical Care)

Education and training

  • Medical School: University of Washington
  • Residency: NewYork-Presbyterian/Weill Cornell Medical Center
  • Fellowship: NewYork-Presbyterian/Weill Cornell Medical Center

What my patients think about me

Average Rating
4.9

261 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

June 2025
5.0
5.0
very timely and professional
May 2025
5.0
5.0
he was understandible
May 2025
5.0
5.0
he was easy to understand and explained everything in detail
April 2025
5.0
5.0
i would recommend

Insurance accepted

My Locations

Learn about location
Learn about location

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Ma is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

DiBardino DM, Andronov M, Haas AR, Lanfranco AR, Ma KC Utility and Safety of Airway Stenting in Distal Airways Stenosis After Lung Transplant , J Bronchology Interv Pulmonol , 27(4): 2020,274-279

Pasricha VG, DiBardino DM, Ma KC Management of malignant central airway obstruction , Shanghai Chest, 4(26): 2020,565-568

Hutchinson CT, DiBardino DM, Ma KC, Jarrar D, Singhal S, Haas AR Airway Stenting for Treatment of Left Lower Lobe Airway Obstruction after Left Upper Lobectomy , Annals of the American Thoracic Society, 16(11): 2019,1444-1446

Ma KC, Chung A, Aronson KI, Krishnan JK, Barjaktarevic IZ, Berlin DA, Schenck EJ Bronchoscopic intubation is an effective airway strategy in critically ill patients. , Journal of Critical Care, 38: 2017,92-96

Ma KC, Schenck EJ, Siempos II, Cloonan SM, Finkelsztein EJ, Pabon MA, Oromendia C, Ballman KV, Baron RM, Fredenburgh LE, Higuera A, Lee JY, Chung CR, Jeon K, Yang JH, Howrylak JA, Huh JW, Suh GY, Choi AMK Circulating RIPK3 levels are associated with mortality and organ failure during critical illness. , JCI insight, 3(13): 2018,e99121

Ma KC, Schenck EJ, Pabon MA, Choi AMK The Role of Danger Signals in the Pathogenesis and Perpetuation of Critical Illness. , American journal of respiratory and critical care medicine, 197(3): 2018,300-309

Sureshbabu A, Edwin E, Ma KC, Laursen K, Finkelsztein EJ, Akchurin O, Muthukumar T, Ryter SW, Gudas L, Choi AMK, Choi ME RIPK3 promotes sepsis-induced acute kidney injury via mitochondrial dysfunction. , JCI insight, 3(11): 2018,e98484

Siempos II, Ma KC, Imamura M, Baron RM, Fredenburgh LE, Huh JW, Moon JS, Finkelsztein EJ, Jones DS, Lizardi MT, Schenck EJ, Ryter SW, Nakahira K, Choi AMK RIPK3 mediates pathogenesis of experimental ventilator-induced lung injury. , JCI insight, 3(9): 2018,e97102

Schenck EJ, Ma KC, Price DR, Nicholson T, Oromendia C, Gentzler ER, Sanchez E, Baron RM, Fredenburgh LE, Huh JW, Siempos II, Choi AMK Circulating cell death biomarker TRAIL is associated with increased organ dysfunction in sepsis. , JCI insight, 4(9): 2019,e101678

Ryter SW, Ma KC, Choi AMK Carbon monoxide in lung cell physiology and disease. , American journal of physiology. Cell physiology, 314(2): 2018,C211-C227

View all publications